Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Refractory Solid Tumors × P7170 compound × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Refractory Solid Tumors 1

Interventions

Radiation Dose Hypofractionation 2 Immune Checkpoint Inhibitors 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 regorafenib 1 envafolimab 1 P7170 compound 1 N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01762410 2014-09-29

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Piramal Enterprises Limited

Phase 1 Suspended

Other solid neoplasm

Advanced Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡